Mutations in the EGFR gene are frequently associated with a variety of cancers, particularly non-small cell lung cancer (NSCLC), and are key drivers of tumor progression (Da Cunha Santos et al. 2011). This evidence concerns the gene EGFR and non-small cell lung carcinoma.